Back to top
more

LifeStance Health Group (LFST)

(Real Time Quote from BATS)

$5.62 USD

5.62
1,004,057

+0.11 (2.00%)

Updated Aug 6, 2024 02:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth D Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (69 out of 251)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for LFST

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for LifeStance Health Group, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 79 109 148 19 3
Receivables 125 101 76 44 19
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 22 24 42 14 5
Total Current Assets 226 233 267 76 27
Net Property & Equipment 188 194 152 59 22
Investments & Advances 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 1,514 1,536 1,505 1,431 230
Deposits & Other Assets 11 11 3 3 1
Total Assets 2,110 2,174 1,927 1,570 281
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 0 0
Accounts Payable 7 12 14 8 4
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 137 106 87 53 28
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 12 19 16 16 23
Total Current Liabilities 203 176 117 76 55
Mortgages 0 0 0 0 0
Deferred Taxes/Income 16 39 54 81 1
Convertible Debt 0 0 0 0 0
Long-Term Debt 280 225 157 363 79
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 1 3 54 52 312
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 681 655 382 572 447
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 0 0 0 0 0
Common Stock (Par) 4 4 4 1,010 0
Capital Surplus 2,184 2,084 1,898 1 0
Retained Earnings -761 -573 -357 -13 -166
Other Equity 2 3 0 0 0
Treasury Stock 0 0 0 0 0
Total Shareholder's Equity 1,429 1,519 1,545 998 -166
Total Liabilities & Shareholder's Equity 2,110 2,174 1,927 1,570 281
Total Common Equity 1,429 1,519 1,545 998 -166
Shares Outstanding 378.60 375.90 374.10 NA NA
Book Value Per Share 3.77 4.04 4.13 -0.01 0.00

Fiscal Year End for LifeStance Health Group, Inc falls in the month of December.

All items in Millions except Per Share data.

6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Assets          
Cash & Equivalents -99,999 49 79 43 80
Receivables NA 176 125 150 122
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 19 22 72 36
Total Current Assets NA 244 226 264 238
Net Property & Equipment NA 182 188 190 193
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 1,502 1,514 1,527 1,537
Deposits & Other Assets NA 12 11 13 11
Total Assets NA 2,106 2,110 2,175 2,171
Liabilities & Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Notes Payable NA 0 0 0 0
Accounts Payable NA 12 7 10 8
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 138 137 175 115
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 8 12 12 14
Total Current Liabilities NA 207 203 241 181
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 16 16 38 38
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 280 280 248 249
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 1 1 3
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 677 681 720 676
Shareholders Equity 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 4 4 4 4
Capital Surplus NA 2,204 2,184 2,163 2,141
Retained Earnings NA -782 -761 -716 -654
Other Equity NA 3 2 4 4
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 1,429 1,429 1,455 1,495
Total Liabilities & Shareholder's Equity NA 2,106 2,110 2,175 2,171
Total Common Equity 0 1,429 1,429 1,455 1,495
Shares Outstanding 382.20 382.20 378.60 378.00 376.70
Book Value Per Share 0.00 3.74 3.77 3.85 3.97